Fig. 6. Wnt7a secreted by OPCs activated β-catenin and upregulated claudin-5 in bEnd.3 cells after OGD.
a Western blot of Wnt7a in Sham, Stroke + PBS, and Stroke + OPC groups. b Western blot revealed Wnt7a increased in Stroke + OPC group after ischemia compared with Stroke + PBS group. Data are mean ± SD, n = 3 per group, *p < 0.05, as compared with Stroke + PBS group, #p < 0.05, as compared with Sham group. S + P: Stroke + PBS; S + O: Stroke + OPC. c Images showed the β-catenin (green) expression of bEnd.3 cells in control (CON), CM of OPC, Wnt7a, and CM of OPC + SI groups at 24 h after OGD. Statistical analysis indicated CM of OPC and Wnt7a could promote β-catenin expression in bEnd.3 cells compared with control. Data are mean ± SD, n = 4 per group, **p < 0.01, as compared with CON group, #p < 0.05, ##p < 0.01, as compared with CM of OPC + SI group. d Images showed the claudin-5 (green) expression of bEnd.3 cells in CON, CM of OPC, Wnt7a, and CM of OPC + SI groups at 24 h after OGD. Data are mean ± SD, n = 4 per group, *p < 0.05, **p < 0.01, as compared with CON group, #p < 0.05, ##p < 0.01, as compared with CM of OPC + SI group. e Experimental setup for Evans blue determination in vitro. f Bar graph indicated the relative permeability of endothelial barrier in vitro. Data are mean ± SD, n = 4 per group, ***p < 0.001, as compared with CON group, ###p < 0.001, as compared with CM of OPC + SI group. Scale bar = 50 µm.
